Previously the first engineer at MyOme and before that, Genomic Prediction. He has nearly a decade of experience in scientific computing.

Previously CTO of Sneller, the world’s fastest log analysis engine. He has a decade of expertise in performance engineering, compiler design, SIMD, and storage systems.

Spent five years investing in early-stage health and biotech ventures, with experience in early commercialization of breakthrough healthcare technologies at Imperial College's Faculty of Medicine and deep research experience at Yale New Haven Hospital and Yale University School of Medicine.

Experienced full stack software engineer with a focus on web frontend development. Created the popular 3D LLM Visualizer, combining expertise in graphics and machine learning.

Previously worked at Texas Instruments specializing in power electronics design and customer design enablement across factory automation, emerging energy, and enterprise applications, focusing on system-level architecture, performance optimization, and compliance.

Biotechnology and health security leader with experience across government and industry. Former senior official at the National Security Council in the Executive Office of the President as well as at the Departments of Defense, Health and Human Services, and State. Prior to this, he was a scientist at USAMRIID. Founder & CEO of Iron Helix, with former leadership roles in venture-backed biotech. Holds a Ph.D. in Virology and an M.S. in Cancer Biology.

Former U.S. Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs. Led U.S. efforts on Ebola response and chemical weapons elimination, and helped secure nuclear materials under the Nunn–Lugar program. Senior Fellow at the Council on Strategic Risks and member of the Council on Foreign Relations.

Assistant Professor in the Division of Translational Science and Therapeutics at the Fred Hutchinson Cancer Center and affiliate Assistant Professor in the Department of Immunology at the University of Washington. He has MD and PhD degrees from the University of Washington. He cares for patients with advanced skin cancer and patients undergoing cell therapies for different cancer types, and leads a research group developing novel T cell therapies for cancer.